Health Care: Drugs

NewLink Genetics Corp (NLNK: NASDAQ)

$41.657 -0.403 | -0.96%
05/26/15 - 12:55 PM ET
Company Profile
Price and Volume
Recent Price 42.06
52 Week High 58.73
52 Week Low 17.32
Avg. Daily Vol. (Mil) 0.70
Beta (3 year) 0.54
Share Related Items
Mkt Cap (Mil) 1,202.76
Shares Out (Mil) 28.60
Float (Mil) 20.68
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 13.20
Current Ratio 14.30
LT Debt/ Equity 0.03
Total Debt / Equity 0.03
Valuation Ratios
Price Earnings 10.50
Price/Sales 5.69
Price/Book 5.17
Price/Cash Flow 9.70
Per Share Data
Earnings 4.00
Sales 7.39
Book Value 8.14
Cash Flow 4.35
Business Summary
NewLink Genetics Corp is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing immunotherapeutic products to improvetreatment options for patients with cancer.
General Information
2503 South Loop Drive
Suite 5100
Ames, IA 50010
www.linkp.com
Industry : Drugs
Sector: Health Care
Employees: 130
CEO: Mr. Charles J. Link, Jr
Short Interest
Current Month (Mil) 4.65
Previous Month (Mil) 5.01
Short Interest Ratio (Days) 7.70
Management Effectiveness
Return on Equity 52.90
Return on Assets 47.60
Return on Investments 51.50
Profitability
Gross Margin n.a.
EBIT Margin 65.60
Profit Margin 58.30

Portfolios with NLNK

Latest NLNK Headlines from TheStreet

More Financial News for NLNK

Press Releases for NLNK

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter